Medicap Healthcare Limited has filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) for its proposed Initial Public Offering (Medicap Healthcare IPO).
The Medicap Healthcare IPO aims to raise ₹2,400 million (₹240 crore) entirely through a Fresh Issue, with no Offer for Sale component.
Medicap Healthcare IPO: Market Position and Business Overview
Medicap Healthcare is a prominent player in India’s pharmaceutical packaging industry, specializing in the production of Euro Head caps and bottle preforms.
Also Read: Prosper AI Secures USD 5M to Solve Healthcare’s USD 450B Administrative Crisis
As of FY2025, the company generated 80.02% of its revenue from domestic sales, while exports to 14 countries contributed the remaining 19.98%.
According to an F&S Report, the company commands a 1.4% global market share and over 40% of the domestic market for Euro Head caps.
Fund Utilization Plans
The proceeds from the Medicap Healthcare IPO will be allocated towards multiple objectives, including:
- ₹743.70 million for the purchase of plant and machinery at its existing manufacturing unit.
- ₹329 million for repayment or prepayment of certain borrowings.
- ₹528 million for investment in subsidiary KASR Healthcare Pvt Ltd, aimed at repayment or prepayment of borrowings.
- Remaining funds for general corporate purposes.
Also Read: CitiusTech Knewron Debuts as AI Platform to Accelerate Healthcare Innovation
Lead Manager
Aryaman Financial Services Limited will act as the sole Book Running Lead Manager for the Medicap Healthcare IPO.
